Literature DB >> 24007769

Transjugular liver biopsy: indications, technique and results.

A Dohan1, Y Guerrache2, M Boudiaf2, J-P Gavini3, R Kaci4, P Soyer5.   

Abstract

Transjugular liver biopsy is a safe, effective and well-tolerated technique to obtain liver tissue specimens in patients with diffuse liver disease associated with severe coagulopathies or massive ascites. Transjugular liver biopsy is almost always feasible. The use of ultrasonographic guidance for percutaneous puncture of the right internal jugular vein is recommended to decrease the incidence of local cervical minor complications. Semiautomated biopsy devices are very effective in obtaining optimal tissue samples for a precise and definite histological diagnosis with a very low rate of complication. The relative limitations of transjugular liver biopsy are the cost, the radiation dose given to the patient, the increased procedure time by comparison with the more common percutaneous liver biopsy, and the need of a well-trained interventional radiologist.
Copyright © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diffuse liver disease; Tissue sample; Transjugular liver biopsy

Mesh:

Year:  2013        PMID: 24007769     DOI: 10.1016/j.diii.2013.08.009

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  13 in total

1.  MR imaging features of liver involvement by Wilson disease in adult patients.

Authors:  Ottavia Vargas; Sid Ahmed Faraoun; Raphael Dautry; Youcef Guerrache; France Woimant; Lounis Hamzi; Mourad Boudiaf; Aurelia Poujois; Philippe Soyer; Anthony Dohan
Journal:  Radiol Med       Date:  2016-04-22       Impact factor: 3.469

Review 2.  Evolution of the liver biopsy and its future.

Authors:  Dhanpat Jain; Richard Torres; Romulo Celli; Jeremy Koelmel; Georgia Charkoftaki; Vasilis Vasiliou
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

3.  Transjugular liver biopsy in severe alcoholic hepatitis.

Authors:  Shiran Shetty; L Venkatakrishnan; J Krishanveni; Shantha Kumari
Journal:  Indian J Gastroenterol       Date:  2017-01-03

Review 4.  Transjugular Liver Biopsy: A Case of a Phrenic Vein Mimic of the Right Hepatic Vein.

Authors:  Mithil B Pandhi; Ali Kord; Matthew M Niemeyer
Journal:  Semin Intervent Radiol       Date:  2022-02-18       Impact factor: 1.513

5.  Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt.

Authors:  Gian Luigi Natali; Giulia Cassanelli; Guglielmo Paolantonio; George Koshy Parapatt; Lorenzo Maria Gregori; Massimo Rollo
Journal:  Pediatr Radiol       Date:  2022-09-19

6.  Accuracy and Safety of 1,055 Transjugular Liver Biopsies in Postliver Transplant Patients.

Authors:  Edward Wolfgang Lee; Megan J Sue; Sammy Saab; Joseph DiNorcia; Justin P McWilliams; Fady Kaldas; Peng-Xu Ding; Siddharth A Padia; Vatche Agopian; Douglas Farmer; Ronald W Busuttil
Journal:  Clin Transl Gastroenterol       Date:  2021-05-21       Impact factor: 4.396

7.  Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.

Authors:  Alyssa Y Choi; Kenneth J Chang; Jason B Samarasena; John G Lee; Xiaodong Li; Wenchang Guo; Vishal S Chandan; Ke-Qin Hu
Journal:  Dig Dis Sci       Date:  2022-03-12       Impact factor: 3.199

8.  Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection.

Authors:  Liangshan Hu; Yan Zhu; Jingqian Zhang; Wei Chen; Zeyong Li; Lihua Li; Liping Zhang; Donglin Cao
Journal:  BMC Infect Dis       Date:  2019-06-14       Impact factor: 3.090

9.  Transjugular Liver Biopsy: Safe Even in Patients With Severe Coagulopathies and Multiple Biopsies.

Authors:  Megan J Sue; Edward W Lee; Sammy Saab; Justin P McWilliams; Francisco Durazo; Mohamed El-Kabany; Fady Kaldas; Ronald W Busuttil; Stephen T Kee
Journal:  Clin Transl Gastroenterol       Date:  2019-07       Impact factor: 4.488

10.  Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.

Authors:  Eric Trépo; Nicolas Goossens; Naoto Fujiwara; Won-Min Song; Antonio Colaprico; Astrid Marot; Laurent Spahr; Pieter Demetter; Christine Sempoux; Gene Y Im; Joan Saldarriaga; Thierry Gustot; Jacques Devière; Swan N Thung; Charlotte Minsart; Thomas Sersté; Gianluca Bontempi; Karim Abdelrahman; Jean Henrion; Delphine Degré; Valerio Lucidi; Laura Rubbia-Brandt; Venugopalan D Nair; Christophe Moreno; Pierre Deltenre; Yujin Hoshida; Denis Franchimont
Journal:  Gastroenterology       Date:  2017-11-20       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.